Despite these seemingly contrasting observations, a recent report that mined The Cancer Genome Atlas data to investigate the association between FADS1 mRNA levels and survival outcomes in over 11,000 subjects (distributed across numerous cancer types) found that patients with higher FADS1 have worse disease-free survival and overall survival rates (35). The gene discussed is FADS1; the disease is cancer.